Goodbye, dad bod: Weight loss medications are changing fathers' physiques — and their relationships with their kids.
Neal Bland has done Ironman competitions and marathons. He's given countless personal training sessions over the course of his life and has always prided himself on staying in shape, especially given that obesity runs in his family. But by age 52, time and genetics had begun to catch up with Bland (who asked that we not use his real last name for privacy reasons).
His blood pressure and blood sugar were climbing, his body mass index was hovering in the low 30s, and his joints were aching. Then, during a photo shoot with his wife last year, the photographer told Bland he 'looked good for a dad bod.' Bland knew the photographer had 'meant it as a compliment,' he tells Yahoo Life, 'but it really stuck.' He was still maintaining a rigorous diet and exercise regimen at the time, but it wasn't working for him. So, in March of 2024, he started on the GLP-1 medication tirzepatide. He's lost 45 pounds in a phase of his life he's dubbed his 'dad bod reboot.'
Let's be clear: There's nothing wrong with a dad bod. In fact, the expectation for men to have chiseled abs — at any point, but especially in middle and older age — can be harmful. But for the 38% of American dads who are obese, their bodies may be putting them at risk of type 2 diabetes, heart disease and other potentially life-threatening medical conditions. Some of these fathers have started taking GLP-1 weight loss medications, a decision that can bring about not just changes to their 'bods' and health indicators, but also to their lives as parents.
We spoke to some of them about what it's like to be a dad, minus their former bods.
Thirty-seven-year-old father of two Noah Wiggins is taking his nursing board exams and looking forward to beginning his new career in health care. 'But I looked in the mirror and thought, I can't expect patients to be healthy and maintain a healthy weight if I can't,' he tells Yahoo Life. Plus, Wiggins loves coaching his children's sports teams, but he found himself getting winded and sore when he tried to demonstrate athletic skills for the kids. While he could shed pounds for a time with the help of various diets, he couldn't maintain a healthy weight long-term. So Wiggins talked to his own health care provider, who agreed that GLP-1 medication could be a good option for him.
He started taking Zepbound in January 2024. The medication, along with the support of his two children, has helped him lose more than 80 pounds since then. 'As I started to lose weight and get more active, they started making comments and encouraging me to make healthy food choices … without judgment,' says Wiggins. His daughter, who is about to turn 16, has been especially vocal, keeping Wiggins accountable when he picks up an unhealthy snack or tries to flake on going to the gym. 'I've had to fight the urge to say, 'I'm the parent, I'll go when I want to,'' says Wiggins. But ultimately, he's grateful for the tough-loving support from his kids. 'I think it's been a growing moment for them and for me,' he says. Wiggins's children have also noticed that he has more energy and can just be more fully present for them.
Despite his progress, Wiggins still struggles with his body image. Like others that Wiggins has spoken to within the GLP-1 community, he half-expected that once the scale reached a certain number, he would feel satisfied with his body and appearance. 'But I don't know anyone who actually hits that number and feels like that,' he says. 'I look in the mirror and am happy with how I look and especially how I feel, but body dysmorphia is a real thing, and a lot of times you don't know you have it until you've lost weight.' At his lowest weight, Wiggins was tempted to lose another 20 pounds to make his reflection match the idealized version of himself in his mind, but he knew that would have put him below a healthy weight.
That's when Wiggins realized that it wasn't about losing more weight. He needed to make a conscious effort to improve his mental health and confidence to help him feel content in his own skin. It's an important lesson that he wants his children to learn: how to 'be comfortable in your body, but balance that with good health,' Wiggins says. He's pushed himself to talk more openly with his kids about his own journey toward striking that balance. 'The best thing to do was just have more conversations with them about all of that, and they'll actually take the lead on those conversations once you start them.'
Twenty years ago, when Ryan Rasmussen and his wife, AnnaLyn, were young newlyweds, they wanted desperately to start a family. After three years of trying, AnnaLyn got pregnant with quadruplets. But tragedy struck: None of the four babies survived more than about an hour after birth. The Rasmussens managed to pick up the pieces of their shattered hearts and eventually went on to have four children, born individually. But even as someone moves on, grief can linger in the body, wreaking havoc. For Rasmussen, the loss of his newborns quietly ate at him and, in turn, Rasmussen now recognizes he ate to cope with his grief. He reached nearly 300 pounds, he told Yahoo Life for our series On My Weigh.
For those intervening 20 years, Rasmussen tried the Atkins diet and various other low-carb eating plans. He'd lose a little weight, then gain back as much or more. In the meantime, his family stayed active and went on ski trips. 'Annalyn is a marathon runner, and she's kept [the kids] in shape, but I think they've probably worried about me,' says Rasmussen. He tried to join their athletic activities, but skiing and hiking were hard on his overburdened joints. Two of his sisters, who also struggled with their weight, found success with GLP-1 medications. Impressed with their progress, Rasmussen tried the new class of weight loss drugs too. Within a year, he dropped 80 pounds. 'Being there for my family was the goal,' he says.
Not only can Rasmussen now join the family ski trips, but hiking and spending time outdoors are day-to-day ways he bonds with his kids. His weight loss 'has definitely allowed us as a family to do more healthy activities,' Rasmussen says. Plus, his good habits have rubbed off on his children. Desserts, once a staple, are reserved for special occasions, and the household's midnight snacking has all but disappeared.
Rasmussen's new body has also allowed him to get back in touch with his fashion sense. 'I like to look good and dress well, but when you're big, [that's] difficult,' he says. Now that he's lost weight, 'being able to dress with purpose in the morning has probably been one of the best things for me and my mental health,' says Rasmussen. And he's not the only one who's noticed his new look. One of his daughter's friends used the viral 'hear me out' cake trend on TikTok as an excuse to show some appreciation for Rasmussen. 'She said, 'hear me out, but Charlie's dad is attractive,'' Rasmussen explains. 'But [Charlie] was a good sport, she laughed about it.'
Bland's now adult children grew up knowing him as the ultra-fit dad, who was always on the go for his job as a pharmaceutical researcher, or hitting the gym to train for his next big event. But he was always fighting against his genetics. 'I come from a long line of fluffy people,' Bland says.
He spent his own childhood watching his mother constantly watch her weight. Despite avoiding smoking and drinking and maintaining a reasonably healthy diet, she eventually had to have both of her knees and one hip replaced and also suffered a stroke, 'all of which can be attributed to [extra] weight on your frame,' says Bland. Recognizing his family's propensity to obesity was part of what drove Bland to be so disciplined. 'But my genetics eventually outran my lifestyle,' he says.
Even with the same routines in place, Bland gained weight in his early 50s, saw his A1C and blood pressure rise, and had inflammation in his hips and knees. And Bland admits that vanity was also a factor. The shirtless man in his vacation photos no longer looked like the version of himself he expected to see. 'I gained about 35 pounds in 10 years; it was the classic 'man-o-pause,'' he says.
Though he didn't meet the clinical qualifications for brand-name GLP-1 medications, Bland tried compounded tirzepatide, suspecting that it would not only help him keep weight off but also reduce the inflammation in his joints. Once he started the medication, 'it was literally like somebody flipped a switch,' says Bland. The food noise (constant, intrusive thoughts about food) disappeared. He no longer ate just because he was bored. The joint pain was barely noticeable, and his workout recovery time improved. He also started to look more like himself in gym selfies.
Bland didn't initially tell his children that he was taking GLP-1 medications. But one of his adult sons noticed that Bland was looking pretty shredded in some of his photos; in fact, he was a bit concerned. He told his father, 'You've lost so much weight and went from really fluffy to really not. Are you sure you're not ... taking PEDs,' meaning performance-enhancing drugs, recalls Bland. Though Bland, now 53, has been taking testosterone replacement therapy for years, that and the GLP-1 have allowed him to return to the weight and energy levels of his younger years. And he's now switched to a very low maintenance dose of tirzepatide to make sure he doesn't lose too much weight. 'It's been a little bit of a return to what they were used to when they were kids,' he says of his new — or, maybe more accurately, restored — bod. 'And I feel like I'm back to the person that my wife married,' Bland adds.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Miami Herald
an hour ago
- Miami Herald
Lilly's experimental obesity drug shows promise in early study
An experimental weight-loss drug from Eli Lilly & Co. helped patients lose weight with few side effects, according to the summary of a small study that suggests the company has another foothold in the obesity market. The drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months, according to an abstract posted Friday ahead of the American Diabetes Association conference in Chicago. The drug is moving to the next stage of development and researchers will present details on dosing and safety at the conference next week. "The data look particularly strong, and should push the program back into investor conversations," Cantor Fitzgerald analyst Prakhar Agrawal wrote in a note to investors. Lilly has shared few details about eloralintide before now, as it's still in the early stages of testing. It's part of a class of drugs that mimic the hormone amylin, which slows digestion and makes people feel full longer. They're thought to be a gentler option for losing weight than currently available injections like Zepbound and Wegovy, which often have side effects like nausea and vomiting. The study enrolled 100 patients who were given different doses of the experimental drug or a placebo for 12 weeks. Weight loss ranged from 2.6% to 11.3%, according to the abstract. Gastrointestinal side effects were relatively minimal, with about 10% of patients experiencing diarrhea and 8% vomiting. Few details were provided, however, including information on risks and benefits based on dose. The promise of drugs that are easier to take than blockbusters like Lilly's Zepbound and its rival Wegovy, from Novo Nordisk A/S, has drawn increasing interest from companies hoping for a piece of pharma's hottest market. In March, Roche Holding AG entered into a $5.3 billion deal to co-develop and commercialize Zealand Pharma A/S' amylin drug, called petrelintide. It is seen as the one to beat in the amylin class, with early trials showing patients lost as much as 8.6% of their body weight in four months, with less nausea than Lilly and Novo's current therapies. AbbVie Inc. agreed to pay as much as $2.2 billion in March for an amylin drug from Danish biotech Gubra A/S, marking its first foray into the obesity market. New York-based startup Metsera Inc. is developing a related compound that may be taken less frequently than weekly shots like Zepbound and Wegovy. Lilly is already a leader in the obesity market, where Zepbound is capturing the majority of new prescriptions. The company has several promising next-generation products in the late stages of development, including a pill called orforglipron and an experimental shot that's thought to be even more effective for weight loss. The company is studying eloralintide alone and in combination with Zepbound - similar to the approach Novo is taking with its next-generation drug CagriSema, which combines an amylin component with semaglutide, the backbone of Wegovy and the diabetes drug Ozempic. Copyright (C) 2025, Tribune Content Agency, LLC. Portions copyrighted by the respective providers.
Yahoo
3 hours ago
- Yahoo
EPA funds $281,000 to Arkansas to reduce lead in children's drinking water
LITTLE ROCK, Ark. – The Environmental Protection Agency is investing in Arkansas drinking water to benefit children. The $281,000 in funding is to reduce lead in drinking water at schools and childcare facilities. Officials said the funding is in addition to the $200 million it has put into reducing lead in drinking water since 2018. EPA announces rollback for some Biden-era limits on 'forever chemicals' in drinking water In addition to this grant program, EPA's Training, Testing, and Taking Action (3T) program provides information and recommendations to help states and local authorities build voluntary programs to reduce lead in drinking water. Since 2019, this 3T program has helped over 20,000 child care facilities and nearly 13,000 schools have their water tested for lead with over 1,300 child care facilities and 2,500 schools completing remediation work. 'Lead is a neurotoxin that can negatively impact American children,' said EPA Administrator Lee Zeldin. 'With $26 million in funding this year, more schools will be able to identify sources of lead in their water and take action so that our nation's children can focus on learning, playing, and developing skills that will maximize their potential and make our nation stronger.' Trump EPA moves to repeal climate rules that limit greenhouse gas emissions from US power plants The Water Infrastructure Improvements for the Nation Act established the Lead Testing in School and Child Care Program Drinking Water grant in 2016 to award funding to states, territories, and tribes to assist local and tribal educational agencies in voluntary testing for lead contamination in drinking water at schools and child care facilities. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
3 hours ago
- Yahoo
Scientists Find That Taking This Vitamin May Help You Live Longer
Most of us grew up with a vague understanding that 'getting our vitamins' was important, but the reasoning wasn't always clear. A new study dives into the specific health benefits of one vitamin in particular—vitamin D—and its findings show that getting enough of it could be the key to living longer and aging healthfully. Meet the Experts: Joseph Mercola, D.O., board-certified family physician and author of Your Guide to Cellular Health; and Amy Davis, R.D., L.D.N., Live Conscious nutrition consultant. The trial followed more than 1,000 healthy American women over 55 years old and men over 50 for a period of four years and found that, compared to placebo, taking 2,000 international units (IU) of vitamin D3 daily helped slow down the shortening of telomeres. Telomeres are 'protective caps on your chromosomes that naturally wear down with age,' explains Joseph Mercola, D.O., board-certified family physician and author of Your Guide to Cellular Health, and they protect DNA during cell division, a process that the body uses to repair and grow. Every time that happens, they get a bit shorter, which makes them a marker of biological age. 'When telomeres get too short, your cells can't divide properly and start to malfunction or die,' Dr. Mercola adds. 'When they shrink too fast, your risk for things like heart disease, cancer, and premature aging symptoms goes up.' At the start of the study, participants had varied vitamin D levels, and those who took vitamin D3 had more telomere protection than those who didn't after four years. 'That's a measurable slowdown in cellular aging,' says Dr. Mercola. Another group in the study took omega-3 supplements and did not experience the same results. Wondering if you're getting enough vitamin D? The National Institute of Health recommends adults not get more than 2000 IU of vitamin D a day. While the study is promising, and there are others like it, there were a few limitations, including the participant pool lacking broad demographic and health diversity, potentially limiting the strength of the findings, explains Amy Davis, R.D., L.D.N., Live Conscious nutrition consultant. Still, both of our experts do think that, in the way of studies, this one was a pretty solid randomized clinical trial. 'While more studies would help clarify the full picture, this adds real credibility to vitamin D3's role in slowing age-related decline,' Dr. Mercola concludes. Vitamin D is known as the 'sunshine vitamin' that may boost mental and bone health. More research is needed to determine exactly how it slows telomere shortening, but it likely has to do with its anti-inflammatory effects, immunity protection, and its role in cell function, particularly within the mitochondria, explains Dr. Mercola. 'Your mitochondria are the energy factories of your cells, and keeping them healthy helps preserve your metabolic power, your resilience, and even your brain function,' he says. 'Vitamin D also supports the production of glutathione, your body's master antioxidant. That means less oxidative stress, fewer damaged proteins and membranes, and slower wear and tear on your cells.' Research shows that oxidative stress may play a role in everything from cancer to rheumatoid arthritis. Of course, as is the case with any supplementation, you should talk to your doctor before going all-in on vitamin D supplements and make sure you're practicing other healthy habits such as eating a Mediterranean-style diet, exercising regularly, getting good sleep, and maintaining an active social life. Your body gets vitamin D through sun exposure, which you naturally absorb safely in small increments, says Dr. Mercola. (Still, don't skip the sunscreen!) 'Your body is built to regulate how much vitamin D it makes from sunlight,' he adds. 'If you supplement, test your levels first.' Your doctor can draw blood and determine if you have a deficiency and if supplements are needed. You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50